期刊
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
卷 11, 期 1, 页码 17-25出版社
TAYLOR & FRANCIS AS
DOI: 10.1586/ERM.10.109
关键词
cellular immunity; CMV; IFN-gamma-release assay; immunocompromised host
类别
Cytomegalovirus (CMV) infection has historically been a major complication among immunocompromised patients, such as solid-organ and stem-cell transplant recipients and patients with advanced HIV infection. While the introduction of antiretroviral therapy has almost eradicated CMV infection in HIV-infected patients, CMV disease remains a significant problem in transplant recipients once antiviral prophylaxis is discontinued. QuantiFERON (R)-CMV allows the assessment of cellular immunity against CMV by detecting the production of IFN-gamma following in vitro stimulation with CMV antigens. Preliminary studies have shown a correlation between a lack of detectable cell-mediated immunity measured by the QuantiFERON-CMV assay and a higher incidence of CMV infection and disease in immunocompromised patients. Measurement of cell-mediated immunity against CMV appears to be a promising strategy to identify patients at highest risk for the development of CMV disease and, therefore, to individualize preventive strategies for CMV in transplant recipients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据